Showing results (1961-1970 of 2,417) with videos related to

Sort By:
Pageof 242
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantationFlorent Malard, Richard M Szydlo, Eolia Brissot, et al.
Haematologica|March 15, 2015
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMarie Thérèse Rubio, Myriam Labopin, Didier Blaise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2011
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignanciesFlorent Malard, Xavier Cahu, Aline Clavert, et al.
Leukemia & Lymphoma|June 30, 2010
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphomaAline Clavert, Steven Le Gouill, Eolia Brissot, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Ejhaem|March 22, 2022
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplantMaxime Jullien, Marianne Coste-Burel, Beatrice Clemenceau, et al.
Haematologica|August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaMohamad Mohty, Florent Malard, Didier Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TCPatrice Chevallier, Mohamad Mohty, Bruno Lioure, et al.
BMC Developmental Biology|July 7, 2007
KIT is required for hepatic function during mouse post-natal developmentLaetitia Magnol, Marie-Clémence Chevallier, Valérie Nalesso, et al.
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
Pageof 242